A Safety Study of NNZ-2566 in Patients With Fragile X Syndrome

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01894958
Recruitment Status : Completed
First Posted : July 10, 2013
Last Update Posted : February 2, 2018
Information provided by (Responsible Party):
Neuren Pharmaceuticals Limited

No Study Results Posted on for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : September 2015
  Actual Study Completion Date : October 2015
  Certification/Extension First Submitted : January 31, 2018